Detalles de la búsqueda
1.
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
Circulation
; 145(5): 321-329, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779221
2.
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial.
Eur Heart J
; 43(47): 4872-4883, 2022 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36030464
3.
Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort.
J Cardiovasc Electrophysiol
; 31(12): 3086-3096, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33022765
4.
The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions.
Catheter Cardiovasc Interv
; 95(5): 1051-1056, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31478304
5.
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.
Eur Heart J
; 40(27): 2218-2227, 2019 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31505615
6.
Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results.
J Cardiovasc Electrophysiol
; 30(11): 2220-2228, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31507001
7.
Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: an analysis of intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction (INFUSE-AMI).
Am Heart J
; 169(1): 86-93, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25497252
8.
Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience.
Eur Heart J
; 35(24): 1599-607, 2014 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24179072
9.
Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial.
Am Heart J
; 166(4): 676-83, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24093847
10.
Anti-N-methyl-D-aspartate receptor encephalitis: an emerging cause of centrally mediated sinus node dysfunction.
Europace
; 14(8): 1188-94, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22345374
11.
Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.
JAMA
; 307(17): 1817-26, 2012 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-22447888
12.
Predictors of atrial fibrillation on implantable cardiac monitoring for cryptogenic stroke.
J Interv Card Electrophysiol
; 65(1): 7-14, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33796969
13.
Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i Trials.
J Am Heart Assoc
; 10(7): e019584, 2021 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33754803
14.
Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
JAMA Netw Open
; 4(4): e216842, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33890991
15.
Real-time stroke volume measurements for the optimization of cardiac resynchronization therapy parameters.
Europace
; 12(9): 1270-4, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20525728
16.
Prognostic significance of QRS fragmentation and correlation with infarct size in patients with anterior ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: Insights from the INFUSE-AMI trial.
Int J Cardiol
; 253: 20-24, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29306465
17.
Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial).
Am J Cardiol
; 119(9): 1295-1301, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28267964
18.
Worsening atrioventricular conduction after hospital discharge in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the HORIZONS-AMI trial.
Coron Artery Dis
; 28(7): 550-556, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28644212
19.
Early Ventricular Tachycardia or Fibrillation in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention and Impact on Mortality and Stent Thrombosis (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial).
Am J Cardiol
; 120(10): 1755-1760, 2017 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28867126
20.
Prognostic implications of Q waves at presentation in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An analysis of the HORIZONS-AMI study.
Clin Cardiol
; 40(11): 982-987, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28696573